Skip to main content

Juno Therapeutics Shares Sky Rocket Following Buyout For $9 Billion

shares of Juno Therapeutics sky rocketed on news that they were going to be bought out by Celgene Corp for $9 billion or $87 per share.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.